Genetic loci for serum magnesium among African-Americans and gene-environment interaction at MUC1 and TRPM6 in European-Americans: The Atherosclerosis Risk in Communities (ARIC) study

BMC Genetics

Volumn 16, Issue 1, 2015, Pages

  Tin, Adrienne ^a   Köttgen, Anna ^a,b   Folsom, Aaron R ^c   Maruthur, Nisa M ^d   Tajuddin, Salman M ^e   Nalls, Mike A ^e   Evans, Michele K ^e   Zonderman, Alan B ^e   Friedrich, Christopher A ^f   Boerwinkle, Eric ^g   Coresh, Josef ^a   Kao, Wen Hong Linda ^g  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF MINNESOTA   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

^f UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^g UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Gene environment interaction; Serum magnesium, MUC1; TRPM6

Indexed keywords

GESTAGEN; INSULIN; MAGNESIUM; MUCIN 1; PROGESTERONE; TRANSIENT RECEPTOR POTENTIAL CHANNEL M6; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM6 PROTEIN, HUMAN;

ADULT; AFRICAN AMERICAN; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MAGNESIUM BLOOD LEVEL; MAGNESIUM METABOLISM; MALE; MUC1 GENE; POSTMENOPAUSE; RACE DIFFERENCE; SHROOM3 GENE; TRPM6 GENE; BLOOD; CAUCASIAN; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MIDDLE AGED; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; ATHEROSCLEROSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INSULIN; MAGNESIUM; MALE; MIDDLE AGED; MUCIN-1; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGESTINS; RISK; TRPM CATION CHANNELS;

EID: 84931077729     PISSN: None     EISSN: 14712156     Source Type: Journal    
DOI: 10.1186/s12863-015-0219-7     Document Type: Article

References (32)

1. Del Gobbo LC, Imamura F, Wu JH, de Oliveira Otto MC, Chiuve SE, Mozaffarian D. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr. 2013;98(1):160-73.
2. Peacock JM, Folsom AR, Arnett DK, Eckfeldt JH, Szklo M. Relationship of serum and dietary magnesium to incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol. 1999;9(3):159-65.
3. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FLCINAIMO, et al. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis risk in communities study. Arch Intern Med. 1999;159(18):2151-9.
4. Tin A, Grams ME, Maruthur NM, Astor BC, Couper D, Mosley TH, et al. Coresh J. Results from the Atherosclerosis Risk in Communities study suggest that low serum magnesium is associated with incident kidney disease. Kidney Int: Kao WH; 2014.
5. Hunter DJ, Lange M, Snieder H, MacGregor AJ, Swaminathan R, Thakker RV, et al. Genetic contribution to renal function and electrolyte balance: a twin study. Clin Sci (Lond). 2002;103(3):259-65.
6. Meyer TE, Verwoert GC, Hwang SJ, Glazer NL, Smith AV, van Rooij FJ, Ehret GB, Boerwinkle E, Felix JF, Leak TS et al.: Genome-wide association studies of serum magnesium, potassium, and sodium concentrations identify six Loci influencing serum magnesium levels. PLoS Genet 2010, 6(8).
7. Resnick LM, Bardicef O, Altura BT, Alderman MH, Altura BM. Serum ionized magnesium: relation to blood pressure and racial factors. Am J Hypertens. 1997;10(12 Pt 1):1420-4.
8. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature. 2007;449(7164):851-61.
9. Nair AV, Hocher B, Verkaart S, van Zeeland F, Pfab T, Slowinski T, et al. Loss of insulin-induced activation of TRPM6 magnesium channels results in impaired glucose tolerance during pregnancy. Proc Natl Acad Sci U S A. 2012;109(28):11324-9.
10. McAuley JL, Linden SK, Png CW, King RM, Pennington HL, Gendler SJ, et al. MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest. 2007;117(8):2313-24.
11. Leroy X, Copin MC, Devisme L, Buisine MP, Aubert JP, Gosselin B, et al. Expression of human mucin genes in normal kidney and renal cell carcinoma. Histopathology. 2002;40(5):450-7.
12. Meseguer M, Aplin JD, Caballero-Campo P, O'Connor JE, Martin JC, Remohi J, et al. Human endometrial mucin MUC1 is up-regulated by progesterone and down-regulated in vitro by the human blastocyst. Biol Reprod. 2001;64(2):590-601.
13. Horne AW, Lalani EN, Margara RA, White JO. The effects of sex steroid hormones and interleukin-1-beta on MUC1 expression in endometrial epithelial cell lines. Reproduction (Cambridge, England). 2006;131(4):733-42.
14. Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22(9):1790-7.
15. GTEx. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013;45(6):580-5.
16. Schlingmann KP, Gudermann T. A critical role of TRPM channel-kinase for human magnesium transport. J Physiol. 2005;566(Pt 2):301-8.
17. de Baaij JH, Groot Koerkamp MJ, Lavrijsen M, van Zeeland F, Meijer H, Holstege FC, et al. Elucidation of the distal convoluted tubule transcriptome identifies new candidate genes involved in renal Mg2+ handling. Am J Physiol Renal Physiol. 2013;305(11):F1563-73.
18. ARIC. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989;129(4):687-702.
19. Coburn JW, Popovtzer MM, Massry SG, Kleeman CR. The physicochemical state and renal handling of divalent ions in chronic renal failure. Arch Intern Med. 1969;124(3):302-11.
20. Evans MK, Lepkowski JM, Powe NR, LaVeist T, Kuczmarski MF, Zonderman AB. Healthy aging in neighborhoods of diversity across the life span (HANDLS): overcoming barriers to implementing a longitudinal, epidemiologic, urban study of health, race, and socioeconomic status. Ethn Dis. 2010;20(3):267-75.
21. Gindler EM, Heth DA. Colorimetric determination with bound "calmagite" of magnesium in human blood serum (abstract). Clin Chem. 1971;17:662.
22. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro 3rd AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-12.
23. Eckfeldt JH, Chambless LE, Shen YL. Short-term, within-person variability in clinical chemistry test results experience from the Atherosclerosis risk in communities study. Arch Pathol Lab Med. 1994;118(5):496-500.
24. Liu CT, Garnaas MK, Tin A, Kottgen A, Franceschini N, Peralta CA, et al. Genetic association for renal traits among participants of African ancestry reveals new loci for renal function. PLoS Genet. 2011;7(9), e1002264.
25. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-75.
26. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26(17):2190-1.
27. Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science. 2012;337(6099):1190-5.
28. Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40(Database issue):D930-4.
29. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care. 2003;26(12):3320-5.
30. McAuley KA, Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, Temple LA, et al. Diagnosing insulin resistance in the general population. Diabetes Care. 2001;24(3):460-4.
31. Park JH, Wacholder S, Gail MH, Peters U, Jacobs KB, Chanock SJ, et al. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet. 2010;42(7):570-5.
32. Marchini J, Howie B. Genotype imputation for genome-wide association studies. Nat Rev Genet. 2010;11(7):499-511.